Twist Bioscience is advancing synthetic DNA manufacturing with innovation but remains at the lower end of its 52-week range.

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2025 fourth quarter and full year ended ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders.

Detailed price information for Twist Bioscience Corp (TWST-Q) from The Globe and Mail including charting and trades.

Detailed price information for Twist Bioscience Corp (TWST-Q) from The Globe and Mail including charting and trades.

The enhanced ability to synthesise DNA, RNA and peptides has transformed biotechnology, enabling tremendous advances in ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

The FDA could announce as soon as this week a change to the black box warning on estrogen products used to treat menopause ...

General Hospital spoilers for the week of November 3 reveal some twists! Fans can expect Emma Scorpio-Drake (Braedyn Bruner) ...